An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer

被引：0
|
作者：
Xin Zhou
Xiaping Wang
Zebo Huang
Lei Xu
Wei Zhu
Ping Liu
机构：
[1] First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[2] Cancer Center of Nanjing Medical University,Key Laboratory of Human Functional Genomics of Jiangsu Province, Clinical Diabetes Centre of Jiangsu Province
[3] Nanjing Medical University,Department of Thoracic Surgery
[4] The Affiliated Jiangning Hospital of Nanjing Medical University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Breast cancer; ER status; miRNA signature; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
    Zhou, Xin
    Wang, Xiaping
    Huang, Zebo
    Xu, Lei
    Zhu, Wei
    Liu, Ping
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [2] Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
    Terranova-Barberio, Manuela
    Pawlowska, Nela
    Dhawan, Mallika
    Moasser, Mark
    Chien, Amy J.
    Melisko, Michelle E.
    Rugo, Hope
    Rahimi, Roshun
    Deal, Travis
    Daud, Adil
    Rosenblum, Michael D.
    Thomas, Scott
    Munster, Pamela N.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [3] Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
    Manuela Terranova-Barberio
    Nela Pawlowska
    Mallika Dhawan
    Mark Moasser
    Amy J. Chien
    Michelle E. Melisko
    Hope Rugo
    Roshun Rahimi
    Travis Deal
    Adil Daud
    Michael D. Rosenblum
    Scott Thomas
    Pamela N. Munster
    Nature Communications, 11
  • [4] An estrogen receptor (ER)-related signature in predicting prognosis of ER-positive breast cancer following endocrine treatment
    Tang, Jianing
    Cui, Qiuxia
    Zhang, Dan
    Liao, Xing
    Zhu, Jian
    Wu, Gaosong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (08) : 4980 - 4990
  • [5] BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
    Pandya, Vrajesh
    Githaka, John Maringa
    Patel, Namrata
    Veldhoen, Richard
    Hugh, Judith
    Damaraju, Sambasivarao
    McMullen, Todd
    Mackey, John
    Goping, Ing Swie
    CELL DEATH & DISEASE, 2020, 11 (06)
  • [6] BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
    Vrajesh Pandya
    John Maringa Githaka
    Namrata Patel
    Richard Veldhoen
    Judith Hugh
    Sambasivarao Damaraju
    Todd McMullen
    John Mackey
    Ing Swie Goping
    Cell Death & Disease, 11
  • [7] Renalase overexpression in ER-positive breast cancer
    Yu, Xuewen
    Han, Pengxun
    Wang, Jiachuan
    Sun, Huili
    Shao, Mumin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1297 - 1307
  • [8] Late recurrence in ER-positive breast cancer
    Gralow, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] The role of the AR/ER ratio in ER-positive breast cancer patients
    Rangel, Nelson
    Rondon-Lagos, Milena
    Annaratone, Laura
    Osella-Abate, Simona
    Metovic, Jasna
    Mano, Maria Piera
    Bertero, Luca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 163 - 172
  • [10] Obesity Associated with Higher Mortality in Women with ER-Positive Breast Cancer
    Printz, Carrie
    CANCER, 2014, 120 (21) : 3267 - 3267
12345